Androgen-deprivation therapy for nonmetastatic prostate cancer is associated with an increased risk of peripheral arterial disease and venous thromboembolism - Hu, J C; Williams, S B; O'Malley, A J; Smith, M R; Nguyen, P L; Keating, N L (Eur Urol, 2012)